Brain's immune system could be harnessed to fight Alzheimer's

November 4, 2015, University of Rochester Medical Center

A new study appearing in the Journal of Neuroinflammation suggests that the brain's immune system could potentially be harnessed to help clear the amyloid plaques that are a hallmark of Alzheimer's disease.

"This research confirms earlier observations that, when activated to fight inflammation, the brain's plays a role in the removal of amyloid beta," said M. Kerry O'Banion, M.D., Ph.D., a professor in the University of Rochester Department of Neurobiology and Anatomy, the Del Monte Neuromedicine Institute, and the lead author of the study. "We have also demonstrated that the immune system can be manipulated in a manner that accelerates this process, potentially pointing to a new therapeutic approach to Alzheimer's disease."

The findings are the culmination of years of investigation that were triggered when O'Banion and his colleagues made a surprising discovery while studying mouse models of Alzheimer's disease. They observed that amyloid beta plaques - which scientists believe play a major role in the disease - were being cleared in animals with chronic brain inflammation.

At the time, the mechanism by which the plaques were being removed was not clear. O'Banion and his colleagues eventually set their sights on microglia, native cells that serve as one the central nervous system's first lines of defense against infection and injury. Microglia are present throughout the brain and spinal cord, are constantly monitoring their environment, and can be switched on or activated to perform different functions such as control inflammation, destroy pathogens, clean up the debris from dead or damaged cells, and seal off the site of an injury.

The researchers conducted a series of experiments to see if they could replicate the phenomenon of amyloid beta clearance absent brain inflammation. This required that they "trick" the microglia into action which was accomplished by injecting a specific protein molecule, a cytokine, into the brain. Cytokines play important roles in cell signaling and the researchers were able to replicate the mechanisms that instruct the microglia to activate an anti-inflammatory response.

Once the microglia were mobilized in mouse models of Alzheimer's disease, the researchers observed a more than 60 percent reduction in amyloid beta in the brain.

"While we still need to fully understand the complexity and potential unintended consequences of this approach, it is clear that microglia play an important role in the removal of from the and may represent a novel approach to treating this disease," said O'Banion.

Explore further: Immune cells are an ally, not enemy, in battle against Alzheimer's

Related Stories

Immune cells are an ally, not enemy, in battle against Alzheimer's

January 29, 2015
Beta-amyloid is a sticky protein that aggregates and forms small plaques in the brains of the elderly and is thought to be a cause of Alzheimer's disease. Because specialized immune cells always surround these plaques, many ...

One step closer to defeating Alzheimer's disease

March 2, 2015
Tackling brain inflammation ameliorates Alzheimer's disease (AD), according to a study published in The Journal of Experimental Medicine.

Boosting the brain's waste disposal system

October 13, 2015
Universitätsmedizin Berlin have been investigating the extent to which macrophages, a type of phagocytic immune cell, might be used to eliminate the abnormal protein deposits typically found in the brains of patients with ...

Researchers identify new gene linked to amyloid beta plaque buildup in Alzheimer's disease

October 5, 2015
In a newly published study, a multi-institutional team led by scientists at the Indiana University School of Medicine have discovered an immune system gene associated with higher rates of amyloid plaque buildup in the brains ...

New findings on the brain's immune cells during Alzheimer's disease progression

April 11, 2013
The plaque deposits in the brain of Alzheimer's patients are surrounded by the brain's own immune cells, the microglia. This was already recognized by Alois Alzheimer more than one hundred years ago. But until today it still ...

Lack of immune cell receptor impairs clearance of amyloid beta protein from the brain

July 1, 2013
Identification of a protein that appears to play an important role in the immune system's removal of amyloid beta (A-beta) protein from the brain could lead to a new treatment strategy for Alzheimer's disease. The report ...

Recommended for you

Genes linked to Alzheimer's contribute to damage in different ways

June 12, 2018
Multiple genes are implicated in Alzheimer's disease. Some are linked to early-onset Alzheimer's, a condition that develops in one's 30s, 40s and 50s, while others are associated with the more common late-onset form of the ...

Researchers reverse cognitive impairments in mice with dementia

June 8, 2018
Reversing memory deficits and impairments in spatial learning is a major goal in the field of dementia research. A lack of knowledge about cellular pathways critical to the development of dementia, however, has stood in the ...

As mystery deepens over the cause of Alzheimer's, researchers seek new answers

June 6, 2018
For more than 20 years, much of the leading research on Alzheimer's disease has been guided by the "amyloid hypothesis."

Research reveals how Tau aggregates can contribute to cell death in Alzheimer's disease

June 5, 2018
New evidence suggests a mechanism by which progressive accumulation of Tau protein in brain cells may lead to Alzheimer's disease. Scientists studied more than 600 human brains and fruit fly models of Alzheimer's disease ...

How does alcohol influence the development of Alzheimer's disease?

June 4, 2018
Research from the University of Illinois at Chicago has found that some of the genes affected by alcohol and inflammation are also implicated in processes that clear amyloid beta—the protein that forms globs of plaques ...

Dementia patients could remain at home longer thanks to ground breaking technology

June 4, 2018
Innovative new technology will enable people with dementia to receive round the clock observation and live independently in their own homes, a new study in the Journal PLOS One reports.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.